SCHEMBL19796448

SCHEMBL19796448

C=CC(=O)OCCOc1cc(C)ccc1-c1ccc(CCO)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 5/20 0.43
THRB P10828 3/20 0.42
FFAR1 O14842 4/20 0.39
TSHR P16473 4/20 0.38
PPARG P37231 1/20 0.38
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
HPGD P15428 1/20 0.37
ALDH1A1 P00352 4/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAPK1 P28482 1/20 0.35
TP53 P04637 2/20 0.35
HIF1A Q16665 2/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804371 0.93 THRB (0.44) FFAR4THRBFFAR1TSHRPPARG
SCHEMBL19804193 0.88 THRB (0.51) FFAR4THRBFFAR1TSHRPPARG
SCHEMBL19796442 0.87 THRB (0.47) FFAR4THRBTSHRCYP4F2CYP4A11
SCHEMBL19804292 0.87 THRB (0.43) FFAR4THRBTSHRALDH1A1TP53
SCHEMBL19804130 0.87 FFAR4 (0.44) FFAR4THRBFFAR1TSHRCYP4F2
SCHEMBL19804294 0.85 THRB (0.42) FFAR4THRBFFAR1TSHRCYP4F2
SCHEMBL19804287 0.85 FFAR4 (0.41) FFAR4THRBFFAR1TSHRCYP4F2
SCHEMBL19804172 0.84 FFAR4 (0.43) FFAR4THRBFFAR1TSHRPPARG
SCHEMBL19801666 0.82 THRB (0.44) THRBALDH1A1L3MBTL1LMNASMN1; SMN2
SCHEMBL19796902 0.82 THRB (0.37) FFAR4THRBTSHRPPARGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 FFAR4 1715/4885THRB 4323/4885FFAR1 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.